Assessing the clinical utility of prescription EPA - What do the latest data suggest?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice Risk Factors and Prevention, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo

Medstar Research Institute, Washington, DC (United States of America)

4 More presentations in this session

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

ESC 365 is supported by